|
CNP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82631687550838E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.00089952887106E-11 |
| Normal-vs-Stage2 |
2.08829999999161E-05 |
| Normal-vs-Stage3 |
1.01330055457538E-10 |
| Normal-vs-Stage4 |
1.93140000004366E-06 |
| Stage1-vs-Stage2 |
5.178800E-01 |
| Stage1-vs-Stage3 |
4.470000E-01 |
| Stage1-vs-Stage4 |
8.329400E-01 |
| Stage2-vs-Stage3 |
8.811000E-01 |
| Stage2-vs-Stage4 |
4.911200E-01 |
| Stage3-vs-Stage4 |
4.551200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.96429547574917E-14 |
| Normal-vs-AfricanAmerican |
4.37339999992403E-07 |
| Normal-vs-Asian |
3.30439999995935E-06 |
| Caucasian-vs-AfricanAmerican |
3.305200E-01 |
| Caucasian-vs-Asian |
4.781400E-01 |
| AfricanAmerican-vs-Asian |
1.154790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34629973835843E-10 |
| Normal-vs-Female |
3.07509573360676E-12 |
| Male-vs-Female |
6.705000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00830011007247E-10 |
| Normal-vs-Age(41-60Yrs) |
2.98483460170473E-12 |
| Normal-vs-Age(61-80Yrs) |
2.79039999995234E-07 |
| Normal-vs-Age(81-100Yrs) |
1.614060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.002000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.596800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.538800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.715200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.944000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.435400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.638000E-01 |
| Classical-VS-Follicular |
1.54789514539289E-11 |
| Classical-VS-Other |
1.835620E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.89311999999608E-05 |
| Tall-VS-Other |
1.486000E-01 |
| Tall-VS-Normal |
2.92930002476766E-09 |
| Follicular-VS-Other |
3.711000E-01 |
| Follicular-VS-Normal |
3.169000E-01 |
| Other-VS-Normal |
3.594300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1166001456786E-10 |
| Normal-vs-N1 |
2.758300E-03 |
| N0-vs-N1 |
1.308420E-01 |
|
|
